Atrial fibrillation: new onset and chronic
Stem
A 69-year-old woman, 72 kg, with hypertension and type 2 diabetes is having a laparoscopic sigmoid colectomy under general anesthesia. Ninety minutes in, with the abdomen insufflated and steep Trendelenburg, the ECG changes to an irregular narrow-complex tachycardia at 148. Blood pressure falls from 118/70 to 84/52. End-tidal CO2 is 46 mmHg and SpO2 97%. She has no history of arrhythmia.
Question
What is happening, and how do you manage it?
Ideal answer
HeadlineNew-onset AF with rapid ventricular response, borderline stable at 84/52 without ischemia. I call for help and the defibrillator, put pads on and tell the surgeon.
- Perfusion threatened or ischemia: synchronized cardioversion, 120–200 J biphasic, synchronized because a shock on the T wave can cause VF.1
- Fix triggers while I decide: deepen if light, more ventilation for the CO2, lower insufflation pressure, a gas with potassium, magnesium and hemoglobin, fluid if dry.
- Stable: rate control under 100 at rest, a beta-blocker such as esmolol or metoprolol, or diltiazem, with phenylephrine supporting pressure.2
- Amiodarone if those fail or her pressure will not tolerate them.2
- Afterward: stroke risk, anticoagulation against bleeding, cardiology follow-up, because perioperative AF often recurs.3
Breaking down the answer
- Unstable or stable first — instability means shock now, rate control later; this is the judgment examiners grade.
- Triggers before drugs — CO2 absorption, light anesthesia, hypovolemia, electrolytes and anemia drive perioperative AF; addressing triggers such as anemia and sepsis is what the guideline asks, and often slows the rate without a drug.3
- Rate drug for the heart — beta-blockers or nondihydropyridine calcium-channel blockers work; digoxin is least effective but useful in heart failure.2 Changes if: a known reduced ejection fraction steers me away from diltiazem.
- Pre-excitation — AV nodal blockers are not used in Wolff-Parkinson-White because they increase conduction down the accessory pathway and can cause VF.2
- Anticoagulation is postoperative — the threshold is an estimated annual stroke risk of 2% or more, and she scores 4 on CHA2DS2-VASc; postoperative anticoagulation is reasonable once bleeding risk allows.4,3
Follow-up question
On the morning of postoperative day 2 she is still in rate-controlled AF and feels well. The surgeon asks you to cardiovert her before discharge. What do you say?
Follow-up answer
HeadlineHer AF has lasted more than 48 hours, so cardioversion now risks embolizing left atrial thrombus. I explain that to the surgeon and her.
She needs more than 3 weeks of anticoagulation before cardioversion, or a TEE to exclude thrombus if we convert now, and in either case anticoagulation for at least 4 weeks afterward.2 With a fresh anastomosis, the bleeding risk of full anticoagulation is the real question, so I bring cardiology and the surgeon together. The usual answer is rate control, anticoagulation once the surgeon agrees, and elective cardioversion later. I reassess her rate and pressure and arrange outpatient cardiology follow-up.3
Pitfalls that cost points
- Cardioverting unsynchronized.
- Reaching for a drug before checking stability and correcting triggers.
Rapid-fire
Q: A patient on apixaban for chronic AF needs surgery: bridge? A: No; DOACs have short half-lives and do not need bridging.5
Q: And on warfarin? A: Withhold it; bridging with heparin adds bleeding and is reserved for high thrombotic risk, such as a mechanical mitral valve.3
Q: When is warfarin preferred over a DOAC? A: In mitral stenosis or a mechanical heart valve.4
Q: What if she cannot take long-term anticoagulation? A: Percutaneous left atrial appendage occlusion is reasonable, Class 2a.4
Q: What is stage 3A AF? A: Paroxysmal AF, intermittent and lasting up to 7 days.4
Numbers to know
| Item | Value |
|---|---|
| Synchronized cardioversion | 120–200 J biphasic1 |
| Resting rate target | Under 100 per minute2 |
| Cardioversion risk window | AF longer than 48 h2 |
| Anticoagulation around cardioversion | More than 3 weeks before, at least 4 weeks after2 |
| Anticoagulation threshold | Annual stroke risk 2% or more4 |
Links
- Mitral regurgitation and mitral stenosis, laparoscopy, ACLS adapted to the operating room, Preoperative cardiac evaluation for non-cardiac surgery, Neuraxial blocks and anticoagulants (ASRA)
- Atlas: Monitor atlas: perioperative cardiac events
- 2023 ACC/AHA/ACCP/HRS atrial fibrillation guideline; 2024 AHA/ACC perioperative guideline
Sources
- 1.Direct-Current (DC) Cardioversion-Defibrillation · Merck Manual Professional Edition · merckmanuals.com
- 2.Atrial Fibrillation · Merck Manual Professional Edition · merckmanuals.com
- 3.2024 AHA/ACC Perioperative CV Management Guideline: Key Points · American College of Cardiology, 2024 · acc.org
- 4.2023 Guideline for Diagnosis and Management of Atrial Fibrillation: Key Perspectives · American College of Cardiology, 2023 · acc.org
- 5.2024 ACC/AHA guideline on perioperative cardiovascular management before noncardiac surgery: What's new? · Cleveland Clinic Journal of Medicine, 2025 · ccjm.orgDOACs do not need bridging; bridging not indicated in most warfarin patients.
Facts on this page were checked against these sources on Oct 15, 2026. Guidelines change; confirm doses against current institutional protocols.